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stents (68.4% to 75%, p0.03). In hospital outcomes were unchanged as shown in the
Figure.
Conclusions: Learning curve of trans-radial approach for experienced trans-femoral
operators does not have an impact on patients’ in hospital outcomes.
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Objective: Carotid stenting has been extensively studied recently as an effective
alternative to endarterectomy in high surgical risk patients. Traditional angiography
involves manual contrast injection and leads to excess contrast volume, greater fluoroscopy
times with an increase in radiation exposure. The Acist contrast injection device helps
with adequate regulation and lowering of contrast volume. The objective of our study is
to see if use of this device during carotid stenting would be feasible without an increase in
primary end points when compared to historic controls.
Methods: This is a consecutive, non-randomized, open label, multiple operator based,
safety/efficacy study. Abbott Vascular, Inc. funded the Choice registry and all patients
were part of this. High surgical risk patients with multiple co-morbid conditions were
included. Inclusion criteria were: a) Subject is considered at high risk for carotid
endarterectomy b) Subject requires percutaneous carotid angioplasty and stenting for
carotid artery disease c) Must be asymptomatic with 80% stenosis of the internal and/or
common carotid artery by ultrasound or angiogram. NIH stroke scale scoring system was
performed on all patients prior to, after and at 30 days from the procedure. The primary
end points measured were, death from any cause, myocardial infarction, transient ischemic
attack or stroke within 30 days of intervention. Secondary end points were contrast volume
and fluoroscopy time. Acist device was used for contrast injection in all patients and
carotid stenting successfully performed.
Results: Four operators in one institution did interventions from June 2007 to May 2012
on 133 consecutive patients. They were predominantly men (59.4%). Mean age (SD) was
73.64 (7.952) years. Stroke occurred in 3% (N4), transient ischemic attack in 0.8%
(N1) and myocardial infarction in 0.8% (N1). Three study subjects died (2.3%). Mean
(SD) contrast volume was 121.24 (67.79) ml. Mean (SD) fluoroscopy time was 18.34
(11.31) minutes.
Conclusions: The use of the Acist device was feasible in carotid stenting in a high-risk
population without an increase in end points when compared to other high-risk studies.
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Background: The individual characteristics of a stent may make it an attractive choice
in one circumstance but render it a less desirable option in other situations, the number
of carotid stents on the market rose steeply, resulting in the plentiful availability of today.
This wide variety of carotid stents can sometimes make the choice of stent to treat a
specific carotid lesion a difficult quest.
Patients and Methods: We studied thirty consecutive patients in a prospective
randomized comparative study including 7 asymptomatic & 23 symptomatic patients
from four Egyptian centers (Ainshams university hospital, National heart Institute,
Nasseer Institute, Cairo-cath center) who underwent carotid artery stenting for a soft
plaque with either closed-cell ( n 10 (33%)), or open-cell (n 20 (66%)) design stents
from the period from august 2008 to march 2010, follow up for 30 days and diffusion
weighted MRI was done for patients post-procedure within 48 hours.
Results: In this study there were only two cases out of the 20 cases of open cell group
that experienced TIA post carotid stenting and there were no cases from the closed cell
group (Carotid Wallstent Monorail®) out of the 10 cases group experienced any
complication.
Conclusion: In our study, it showed that closed stent cell design demonstrated
statistically nonsignificant less complication at 30-days compared to open stent cell design.
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The present study was conducted in patients with Parkinson’s disease (PD) with the
objective to evaluate the safety (primary end point) and potential efficacy (secondary end
point) of intra-arterial administrations of Autologous Unfractionated Bone Marrow
(AUBM) cells.
Methods: To achieve this, we conducted a clinical trial in 10 PD patients diagnosed per
an experienced neurologist. A target volume of 120 ml of AUBM was infused
intra-arterially into internal carotid and vertebral arteries. Safety analysis procedure related
and follow up were evaluated. Neurological evaluation at baseline,1, 3, 6 and 12 months
follow-up were evaluated by Hoehn and Yahr scale (H & Y), Unified Parkinson’s Disease
Rating Scale (UPDRS) and Schwab and England scale (S&E). Neuroimaging study
either with perfusion Computed Tomography (CT) or Brain Perfusion Spect 99m Tc
(PS) were conducted at baseline, 1 and 12 months follow-up. Cerebral Digital Subtraction
Angiography (DSA) was performed.
Results: Mean age 68 9 years, male 70%, with a mean duration of onset of the disease
9  4 years. There were no procedure-related adverse events and during follow-up of
12  4 months. Significant neurological improvement was observed in the mean
follow-up score in H&Y from 3.7  0.82 to 2.25  0.82 (p 0,001), in UPDRS from
64 32 to 38 32 (p 0,004) and in S&E from 52% 17% to 73% 14% (p 0,001).
Perfusion CT performed in 4 patients showed improvements in perfusion with mean
baseline peak arterial enhancement of 122  47 pixels to 204  32 pixels in the follow
up. Brain PS conducted in 6 patients showed areas of hypoperfusion in 4 patients with
significant improvements in follow-up, in 2 patients were normal and unchanged in the
follow up. Improvements in clinical score and neuroimaging study were observed in 8 of
10 patients (80%). The 2 patients who did not improve had normal PS study. The
cerebral DSA images were evaluated by an independent neuroradiology laboratory
with the following findings: bovine aortic arch in 8 patients (80%), fetal origin of
the posterior cerebral artery in 4 patients (40%), hypoplasia A1 of anterior cerebral
artery in 5 patients (50%).
Conclusions: Present study gives evidence that PD patients the intra-arterial route for
delivery of cells such as AUBM is safe. A correlation between the clinical Improvements
and cerebral perfusion was found. The number of patients recruited and the uncontrolled
nature of the study did not permit demonstration of effectiveness of the treatment
involved. However, the results encourage future studies with more patients to demonstrate
efficacy.
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